Medicines with stricter reporting requirements Individual reimbursement Danish drug interaction databases Compassionate use permits Healthcare professionals having a relationship with a company Report a side effect from medicines Reporting of incidents and accidents with medical devices Medicinal cannabis Veterinary medicines
Theme

Vaccines against COVID-19

Medicines agencies around the world are collaborating to approve and follow vaccines against COVID-19. Once the vaccines are approved, medicines authorities around the world follow up with monitoring of adverse drug reactions. Read about results, processes and new vaccines against COVID-19 in our three themes or in the question-and-answer below.

Go to theme

News and notifications

New executive order raises fees in the area of the Danish Medicines Agency

03 May 2022

Higher fees become payable for medicinal products and pharmaceutical companies as a result of a new executive order entering into force on 1 May 2022. The last time the fees were adjusted was in 2017.

Danish Medicines Agency presents new strategy

05 April 2022

2021 deadline for submitting applications concerning marketing authorisations and clinical trials

08 November 2021

Danish Medicines Agency investigates a case of inflammatory condition reported after COVID-19 vaccination

26 August 2021